Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Scientists at Roche disclose new HDL cholesterol-raising agents

July 17, 2012

In vivo results for ARRY-981 presented

July 16, 2012

Intranasal CP-024 leads to IGF-I induction in healthy volunteers

July 16, 2012

New fusion protein from Bristol-Myers Squibb demonstrates antidiabetic activity

July 16, 2012

Japanese team discloses novel treatments for diabetes

July 16, 2012

Orexigen Therapeutics reports early enrollment in the Light study

July 13, 2012

GSK receives final phase III data for albiglutide

July 13, 2012

Merck & Co. provides update on phase III odanacatib trial

July 13, 2012

Arena Pharmaceuticals files for approval of lorcaserin in Switzerland

July 13, 2012

Recruitment complete in phase III NX-1207 trial

July 12, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...